BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Transcription profiling of human 786-O clear cell renal carcinoma cells reveals small molecule inhibitors of HIF-2a translation link its...

Dataset: Transcription profiling of human 786-O clear cell renal carcinoma cells reveals small molecule inhibitors of HIF-2a translation link its 5 UTR Iron-Responsive Element (IRE) to oxygen sensing

Cells transiently adapt to hypoxia by globally decreasing protein translation. However, specific proteins needed to respond to hypoxia...

Registered by ArrayExpress Uploader
View Dataset

Cells transiently adapt to hypoxia by globally decreasing protein translation. However, specific proteins needed to respond to hypoxia evade this translational repression. The mechanisms of this phenomenon remain unclear. We screened for and identified small molecules that selectively decrease HIF-2a translation in an mTOR independent manner, by enhancing the binding of Iron Regulatory Protein 1 (IRP1) to a recently reported Iron-Responsive Element (IRE) within the 5’-untranslated region (UTR) of the HIF-2a message. Knocking down the expression of IRP1 by shRNA abolished the effect of the compounds. Hypoxia de-represses HIF-2a translation by disrupting the IRP1- HIF-2a IRE interaction. Thus, this chemical genetic analysis describes a molecular mechanism by which translation of the HIF-2a message is maintained during conditions of cellular hypoxia through inhibition of IRP-1 dependent repression. It also provides the chemical tools for studying this phenomenon. Experiment Overall Design: 3 replicate samples of 786-O human Clear Cell Renal Carcinoma cells untreated, mock treated with DMSO or treated with either of 4 HIF-2a inhibitor compounds identified by chemical genetic screening.

Species:
human

Samples:
26

Source:
E-GEOD-13818

Updated:
Dec.12, 2014

Registered:
Sep.11, 2014


Factors: (via ArrayExpress)
Sample Treatment
GSE13818GSM347637 negative control
GSE13818GSM347642 vehicle (DMSO)
GSE13818GSM347644 HIF-2a shRNAi
GSE13818GSM347646 shRNA vector only control
GSE13818GSM347647 Compound 40
GSE13818GSM347649 Compound 41
GSE13818GSM347650 Compound 76
GSE13818GSM347652 Compound 77
GSE13818GSM347654 vector only
GSE13818GSM347656 VHL reconstituted
GSE13818GSM347654 vector only
GSE13818GSM347654 vector only
GSE13818GSM347660 VHL reconstituted
GSE13818GSM347660 VHL reconstituted
GSE13818GSM347652 Compound 77
GSE13818GSM347667 negative control
GSE13818GSM347642 vehicle (DMSO)
GSE13818GSM347670 Compound 41
GSE13818GSM347637 negative control
GSE13818GSM347642 vehicle (DMSO)
GSE13818GSM347649 Compound 41
GSE13818GSM347679 Compound 76
GSE13818GSM347650 Compound 76
GSE13818GSM347684 Compound 77
GSE13818GSM347699 Compound 40
GSE13818GSM347699 Compound 40

Tags

  • carcinoma
  • cell
  • clear cell
  • protein
  • renal carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use